You mischaracterize the article. It mentions the FDA, and perhaps more importantly other disincentives.

Hospitals desire more expensive solutions because they get paid more for them. That is a second, enormous barrier.

The incentives are clear here. The costs are high, between regulations, marketing, out-maneuvering rent-seeking incumbents, and cultural issues. The reward is low. No one will become a billionaire for doing this work.